On the other hand, Shin et al., in their studies on animal models, demonstrated that dapagliflozin reduced OS by increasing MnSOD, Cu/ZnSOD, and catalase expression in renal tissues of animals with diabetic kidney disease [5]. This evidence concerns the gene CAT and diabetic kidney disease.